Literature DB >> 12713742

Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK.

Azra C Ghani1, Neil M Ferguson, Christl A Donnelly, Roy M Anderson.   

Abstract

Following the emergence of a new variant of Creutzfeldt-Jakob disease (vCJD) 6 years ago, and the gradual rise in clinical cases, there has been increased speculation regarding the overall magnitude of this epidemic in Great Britain. In this paper, we explore the epidemiological factors and uncertainties determining the scale of this epidemic in light of the most recent data on reported vCJD mortality. Our results demonstrate that, while the magnitude of the uncertainty has decreased dramatically since 1996, it is still not possible to predict with any degree of accuracy the final magnitude of this epidemic, with the 95% confidence interval for future cases being from 10 to 7000 deaths. However, short-term projections show that it is unlikely that a dramatic increase in case numbers will be observed in the next 2-5 years (95% confidence interval for 2 years: 10-80 cases, for 5 years: 10-200 cases). The results confirm significant age-dependent susceptibility/exposure to infection, with the likelihood profile demonstrating that those aged between 10 and 20 years are at highest risk of infection. We also demonstrate how projections based on onset data may be substantially biased, and explore the sensitivity of results to assumptions concerning the exposure to bovine spongiform encephalopathy (BSE) and the incubation-period distribution.

Entities:  

Mesh:

Year:  2003        PMID: 12713742      PMCID: PMC1691299          DOI: 10.1098/rspb.2002.2313

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  35 in total

1.  Predicted vCJD mortality in Great Britain.

Authors:  A C Ghani; N M Ferguson; C A Donnelly; R M Anderson
Journal:  Nature       Date:  2000-08-10       Impact factor: 49.962

2.  Plasminogen binds to disease-associated prion protein of multiple species.

Authors:  M Maissen; C Roeckl; M Glatzel; W Goldmann; A Aguzzi
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

3.  Incidence of variant Creutzfeldt-Jakob disease in the UK.

Authors:  N J Andrews; C P Farrington; S N Cousens; P G Smith; H Ward; R S Knight; J W Ironside; R G Will
Journal:  Lancet       Date:  2000-08-05       Impact factor: 79.321

4.  Identification of multiple quantitative trait loci linked to prion disease incubation period in mice.

Authors:  S E Lloyd; O N Onwuazor; J A Beck; G Mallinson; M Farrall; P Targonski; J Collinge; E M Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

5.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.

Authors:  J D Wadsworth; S Joiner; A F Hill; T A Campbell; M Desbruslais; P J Luthert; J Collinge
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

6.  Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000.

Authors:  S Cousens; P G Smith; H Ward; D Everington; R S Knight; M Zeidler; G Stewart; E A Smith-Bathgate; M A Macleod; J Mackenzie; R G Will
Journal:  Lancet       Date:  2001-03-31       Impact factor: 79.321

7.  Assessment of the prevalence of vCJD through testing tonsils and appendices for abnormal prion protein.

Authors:  A C Ghani; C A Donnelly; N M Ferguson; R M Anderson
Journal:  Proc Biol Sci       Date:  2000-01-07       Impact factor: 5.349

8.  Scrapie infections initiated at varying doses: an analysis of 117 titration experiments.

Authors:  A R McLean; C J Bostock
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-08-29       Impact factor: 6.237

Review 9.  Iatrogenic Creutzfeldt-Jakob disease at the millennium.

Authors:  P Brown; M Preece; J P Brandel; T Sato; L McShane; I Zerr; A Fletcher; R G Will; M Pocchiari; N R Cashman; J H d'Aignaux; L Cervenáková; J Fradkin; L B Schonberger; S J Collins
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

10.  Variant Creutzfeldt-Jakob disease in an elderly patient.

Authors:  J W Lorains; C Henry; D A Agbamu; M Rossi; M Bishop; R G Will; J W Ironside
Journal:  Lancet       Date:  2001-04-28       Impact factor: 79.321

View more
  13 in total

1.  Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility.

Authors:  Paul Clarke; Azra C Ghani
Journal:  J R Soc Interface       Date:  2005-03-22       Impact factor: 4.118

2.  Complex causal process diagrams for analyzing the health impacts of policy interventions.

Authors:  Michael Joffe; Jennifer Mindell
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

3.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

4.  Resistance of neonatal mice to scrapie is associated with inefficient infection of the immature spleen.

Authors:  Michelle Ierna; Christine F Farquhar; George W Outram; Moira E Bruce
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 5.  Non-human primates in prion diseases.

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Jean-Philippe Deslys
Journal:  Cell Tissue Res       Date:  2022-06-04       Impact factor: 5.249

6.  Assessment of the risk posed by bovine spongiform encephalopathy in cattle in Great Britain and the impact of potential changes to current control measures.

Authors:  Neil M Ferguson; Christl A Donnelly
Journal:  Proc Biol Sci       Date:  2003-08-07       Impact factor: 5.349

7.  Human prion disease and relative risk associated with chronic wasting disease.

Authors:  Samantha Mawhinney; W John Pape; Jeri E Forster; C Alan Anderson; Patrick Bosque; Michael W Miller
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

8.  Updated projections of future vCJD deaths in the UK.

Authors:  Azra C Ghani; Christl A Donnelly; Neil M Ferguson; Roy M Anderson
Journal:  BMC Infect Dis       Date:  2003-04-27       Impact factor: 3.090

9.  Host culling as an adaptive management tool for chronic wasting disease in white-tailed deer: a modelling study.

Authors:  Gideon Wasserberg; Erik E Osnas; Robert E Rolley; Michael D Samuel
Journal:  J Appl Ecol       Date:  2009-04       Impact factor: 6.528

10.  vCJD risk in the Republic of Ireland.

Authors:  Michael S Harney; Azra C Ghani; C A Donnelly; Rory McConn Walsh; Michael Walsh; Rachel Howley; Francesca Brett; Michael Farrell
Journal:  BMC Infect Dis       Date:  2003-11-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.